Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential ...

Conroy said the upgraded version raises the bar for noninvasive screening, with 95% sensitivity and 94% specificity cutting ...

After an increase in colorectal cancer among patients younger than 50, U.S. guidelines started recommending that screening begin at age 45 for average-risk adults. This study showed that ...

More specifically, colorectal cancer can be one of the deadliest types of cancer when diagnosed at an advanced stage. But ...

Screening is an effective tool for reducing the burden of cancer,” per Fred Hutch public health researcher Chris Li. “But it's a complex process with multiple steps." Unfortunately, many Americans are ...

Early cancer screening not just detects diseases early in India but identifies potential problems long before they grow out ...

Cancer incidence is rising around the world, but an international study is challenging the popular narrative that young people are at risk.

Across all ages, ADC incidence did not significantly vary, whereas NEN rates rose from 2004 to 2013, increasing between 10.1% (95% CI, 4.0%-16.5%) and 12.6% (95% CI, 7.2%-18.2%) per year before ...

The latest announcement is out from Rhythm Biosciences Ltd. ( ($AU:RHY) ). Rhythm Biosciences Ltd. presented a post-AGM update, highlighting ...

The firm is now offering combined ex vivo drug sensitivity and genomic testing to cancer patients outside the clinical trial setting.

In a major breakthrough, scientists at the School of Medicine have found a way to transform immune cells that normally ...